Additionally, damaged mitochondria in CRC cells can release mtDNA into the cytosol, activating the cGAS-STING pathway in a context-dependent manner either enhancing type I interferon mediated immune surveillance or, when chronically activated, promoting immune tolerance and checkpoint therapy resistance (27, 261, 262). This evidence concerns the gene CGAS and colorectal carcinoma.